COVID-19 Literature Situation Report
COVID-19 Literature Situation Report is a daily (M-F) newsletter that provides a succinct summary of the latest scientific literature related to the COVID-19 pandemic.
The scientific literature on COVID-19 is rapidly evolving and these articles were selected for review based on their relevance to Washington State decision making around COVID-19 response efforts. Included in these Lit Reps are some manuscripts that have been made available online as pre-prints but have not yet undergone peer review. Please be aware of this when reviewing articles included in the Lit Reps.
Click the SUBSCRIBE button in the right-hand column to subscribe to daily reports delivered to your inbox.
October 13, 2020
COVID-19 Literature Situation Report Oct. 13, 2020
A man from Nevada was reported as the first case of SARS-CoV-2 reinfection in North America, with genomic evidence supporting that the first infection in May and the second in June were from separate occasions. Symptoms were more severe during the second infection. More
October 12, 2020
COVID-19 Literature Situation Report Oct. 12, 2020
More than 815,000 deaths due to COVID-19 globally could be prevented by universal mask use between August 26, 2020 and January 1, 2021, based on recent IHME projections
October 9, 2020
COVID-19 Literature Situation Report Oct. 9, 2020
Children with asthma or obesity who were hospitalized with SARS-CoV-2 were at increased risk for critical care admission or need for respiratory support.
October 8, 2020
COVID-19 Literature Situation Report Oct. 8, 2020
The most common motivations for social distancing among survey respondents in North America and Europe were wanting to protect others, self-protection, and feeling a sense of responsibility to protect the community.
October 7, 2020
COVID-19 Literature Situation Report Oct. 7, 2020
The BLAZE-1 clinical trial found that a combination of two monoclonal antibodies showed evidence of efficacy for treatment of mild-to-moderate COVID-19. These findings are based on a press release and have not been peer reviewed.
October 6, 2020
COVID-19 Literature Situation Report Oct. 6, 2020
Lopinavir-ritonavir was not associated with a reduction in 28 day all-cause mortality, duration of hospital stay, or death in a randomized open-label trial (RECOVERY Trial).
October 5, 2020
COVID-19 Literature Situation Report Oct. 5, 2020
Approximately three-quarters of people who required hospitalization for COVID-19 reported at least one lingering symptom or effect 3 months after their symptoms began. The most frequently reported effects were reduced quality of life (51%) and shortness of breath (50%).
October 2, 2020
COVID-19 Literature Situation Report Oct. 2, 2020
A study of viral genomes from Washington State indicated that the timing of mitigation strategies and repeated introductions of viral lineages into the state likely shaped the relative distribution of different lineages of SARS-CoV-2, rather than differences in transmissibility between variants of the virus.
October 1, 2020
COVID-19 Literature Situation Report Oct. 1, 2020
SARS-CoV-2 contact investigations in two Indian states showed the distribution of COVID-19 cases and deaths was younger than previously observed in the US, and is not explained by differences in underlying age of the populations. Risk of infection was higher among similar-age contacts, and most contacts who tested positive were exposed to an index case aged 20-44 years.
September 30, 2020
COVID-19 Literature Situation Report Sept. 30, 2020
Among patients hospitalized with COVID-19 in the US, prior psychiatric diagnosis was associated with a higher mortality rate after controlling for demographic characteristics, other comorbidities, and hospital locations.
Previous page Next page